All are welcome to join BRI-Icahn and Primary Care Progress for this panel discussion presentation on transforming outpatient medicine. We will be hearing from three speakers who will each give a 10-15 minute “TED” style talk about how their practices are transforming outpatient medicine and primary care.

SPEAKERS:

Fidela Chiang, NP, Institute for Family Health | School-based medicine
Robin Berzin, MD, Parsley Health | Concierge practice focusing on individualized medicine

Andy Coyle, MD, Asst. professor of Medicine, General Internal Medicine, and Medical Education, Icahn School of Medicine at Mount Sinai | Dr. Coyle focuses on homeless medicine

Prescription-drug prices continue to seize headlines this election season. Recent drug-pricing scandals—involving EpiPen and Daraprim, older medicines used to treat asthma and malaria, respectively, as well as high list prices for new medicines to counter hepatitis C and cholesterol—seem to offer ammunition to critics who charge that drug manufacturers prioritize profits over patients.

But how are drug prices in the U.S. actually determined? Are the forces of competition being fully harnessed to yield positive results for patients? And how is high-deductible insurance, accelerating fast under Obamacare, affecting access to critical medicines?

Please join Manhattan Institute for a health-care symposium, as distinguished experts discuss the forces driving drug pricing in America—and explore promising new approaches for making medicines more affordable for patients.

All are welcome to attend a discussion with Dr. Emilie Scott & Dr. James Gaor of Halcyon Health. What is Direct Primary Care (DPC), and how is it relevant to medical students? Dr. Scott will speak about her primary care practice, which uses the direct primary care business model. In this model, patients pay an initial enrollment fee and then a monthly fee for primary care services.We think you'll want to know about this non-traditional and expanding method of delivering quality, affordable care without insurance companies or government middlemen getting between patients and doctors.